Georgia Medicare Mammography Screening 2026 Guide

By Brevy Care Team

Medicare covers screening mammography for eligible women beneficiaries through a benefit established by Section 4163 of the Omnibus Budget Reconciliation Act of 1990 (OBRA 90, Public Law 101-508), codified at Section 1861(jj) of the Social Security Act (42 U.S.C. 1395x(jj)), and implemented at 42 CFR 410.34. The original benefit, effective January 1, 1991, has been substantially expanded since, most importantly by Section 4101 of the Balanced Budget Act of 1997 (BBA, Public Law 105-33) which established annual screening mammography frequency for women age 40 and older. The benefit also incorporates the Mammography Quality Standards Act (MQSA, Public Law 102-539) facility certification requirements that ensure quality standards across all mammography facilities serving Medicare beneficiaries.

For Georgia Medicare women beneficiaries, the mammography screening benefit is one of the most important preventive services in the Medicare statute. Breast cancer is the most common cancer in women in the United States and a leading cause of cancer death. Georgia faces particular breast cancer mortality concerns: African American women in Georgia experience breast cancer mortality at rates approximately 40 percent higher than non-Hispanic white women despite similar incidence rates, reflecting late-stage diagnosis at presentation, treatment access disparities, and persistent socioeconomic health disparities. Rural Georgia counties face mammography access challenges that are partially addressed by mobile mammography services and regional referral patterns. This guide explains the statutory framework, eligibility rules, covered technologies (including digital mammography and digital breast tomosynthesis), HCPCS coding, MQSA facility certification, cost-sharing under the ACA Section 4104 waiver, coordination with diagnostic mammography and supplemental imaging, and the Georgia breast imaging landscape so beneficiaries, families, and clinicians can navigate the benefit effectively.

Key Takeaways

1. Statutory authority: Section 1861(jj) of the Social Security Act defines screening mammography as a covered Medicare service. The benefit was added by Section 4163 of the Omnibus Budget Reconciliation Act of 1990 (Public Law 101-508), signed November 5, 1990, with coverage effective January 1, 1991.
2. Annual frequency expansion: Section 4101 of the Balanced Budget Act of 1997 (Public Law 105-33) established annual screening mammography frequency for women age 40 and older effective January 1, 1998.
3. Implementing regulation: 42 CFR 410.34 specifies the regulatory framework including covered services, frequency limits, facility requirements, and provider requirements.
4. Annual screening for women age 40 and older: Medicare covers one screening mammography every 12 months for women age 40 and older. The annual frequency reset is calculated from the first day of the month following the most recent screening mammography.
5. Baseline screening for women age 35 to 39: Medicare covers a one-time baseline screening mammography for women age 35 to 39. This benefit primarily applies to women who enroll in Medicare early through disability eligibility before reaching age 40.
6. Covered technologies: Medicare covers both standard digital mammography and digital breast tomosynthesis (DBT, also known as 3D mammography). The DBT add-on (HCPCS 77063) may be billed in addition to the standard screening mammography (HCPCS 77067) when DBT imaging is performed.
7. HCPCS coding: 77067 (screening mammography bilateral two-view), 77063 (screening DBT add-on), 77066 (diagnostic mammography bilateral), 77065 (diagnostic mammography unilateral).
8. MQSA facility certification: The Mammography Quality Standards Act (Public Law 102-539) requires that all mammography facilities serving Medicare beneficiaries be MQSA-certified. The FDA administers the MQSA program through facility accreditation, annual inspections, and quality standards.
9. ACA cost-sharing waiver: Section 4104 of the Affordable Care Act eliminated Part B deductible and coinsurance for USPSTF Grade B aligned screening mammography effective January 1, 2011. Beneficiaries pay $0 for screening mammography when furnished by a Medicare-accepting provider.
10. Georgia landscape: Major Georgia breast imaging programs include Emory Breast Imaging Center, Wellstar Breast Care, Piedmont Breast Health, Northside Comprehensive Breast Care, and Augusta University Breast Health Center. Mobile mammography services provide critical access for rural Georgia counties. African American women in Georgia face elevated breast cancer mortality despite similar incidence rates.

Part 1: The Statutory and Regulatory Framework

Section 1861(jj) of the Social Security Act

Section 1861(jj) of the Social Security Act (42 U.S.C. 1395x(jj)) defines "screening mammography" for Medicare coverage purposes as a radiologic procedure provided to a woman for the purpose of early detection of breast cancer that includes a physician's interpretation of the results. The statute requires that screening mammography be performed in a facility that meets the standards established by the Secretary of Health and Human Services under the Mammography Quality Standards Act.

The statute distinguishes screening mammography from diagnostic mammography. Screening mammography is performed in asymptomatic women for early detection. Diagnostic mammography is performed to evaluate symptoms (palpable mass, breast pain, nipple discharge), to evaluate abnormal findings from a screening mammography, or to follow up after breast cancer treatment.

OBRA 1990 Section 4163 Origin

The screening mammography benefit was established by Section 4163 of the Omnibus Budget Reconciliation Act of 1990 (OBRA 90, Public Law 101-508), signed by President George H.W. Bush on November 5, 1990. The benefit became effective for services furnished on or after January 1, 1991.

The original frequency rules were more restrictive than current frequency:

• Women age 35 to 39: One baseline screening mammography.
• Women age 40 to 49: Screening mammography every 2 years.
• Women age 50 to 64: Screening mammography every 2 years.
• Women age 65 and older: Screening mammography every 2 years.

BBA 1997 Section 4101 Annual Frequency Expansion

Section 4101 of the Balanced Budget Act of 1997 (BBA, Public Law 105-33) substantially expanded the screening mammography benefit by establishing annual frequency for women age 40 and older effective January 1, 1998. The current frequency rules under BBA 1997 are:

• Women age 35 to 39: One baseline screening mammography.
• Women age 40 and older: Screening mammography every 12 months (annual).

The annual frequency reset is calculated from the first day of the month following the most recent screening mammography. For example, if a beneficiary has a screening mammography on June 15, 2026, her next annual screening mammography is covered on or after July 1, 2027.

42 CFR 410.34 Implementing Regulations

The implementing regulations for screening mammography are codified at 42 CFR 410.34. The regulations specify:

• The frequency limits for screening mammography by age category.
• The facility requirements including MQSA certification.
• The radiologic technologist requirements.
• The interpreting physician requirements.
• The technology coverage including standard digital mammography and digital breast tomosynthesis (DBT).
• The coordination with diagnostic mammography when abnormal findings require additional imaging.

Mammography Quality Standards Act (MQSA)

The Mammography Quality Standards Act of 1992 (MQSA, Public Law 102-539), signed by President George H.W. Bush on October 27, 1992, is administered by the U.S. Food and Drug Administration (FDA) and establishes quality standards for all mammography facilities in the United States. MQSA requirements include:

• Facility accreditation by an FDA-approved accrediting body (American College of Radiology, several state accreditation programs).
• Annual FDA facility inspection.
• Personnel qualifications for interpreting physicians, radiologic technologists, and medical physicists.
• Equipment standards.
• Quality assurance and quality control programs.
• Mammography Reporting and Data System (BI-RADS) reporting standards.
• Patient communication of mammography results.

Medicare covers screening mammography only at MQSA-certified facilities. The FDA maintains a public database of MQSA-certified facilities accessible through the FDA website.

Related Statutory and Regulatory Authority

Several other Medicare preventive services statutes coordinate with the mammography screening benefit:

• Section 1861(ww) SSA — Initial Preventive Physical Examination (IPPE, Welcome to Medicare visit).
• Section 1861(hhh) SSA — Annual Wellness Visit (AWV).
• Section 1861(ddd) SSA — General preventive services framework.
• ACA Section 4104 (Public Law 111-148) — Preventive services cost-sharing waiver effective January 1, 2011.

Part 2: Eligible Beneficiaries

Age Eligibility

Medicare covers screening mammography for women beneficiaries based on age:

Women age 35 to 39: One-time baseline screening mammography. This benefit primarily applies to women who enroll in Medicare early through disability eligibility before reaching age 40. Most Medicare women beneficiaries enroll at age 65, so the baseline benefit for age 35 to 39 has limited applicability for the typical aging-in beneficiary.

Women age 40 and older: Annual screening mammography. There is no upper age limit. Women in their 80s and 90s remain eligible for annual screening mammography under Medicare. The clinical decision to continue screening at advanced age is typically made through shared decision-making considering life expectancy, comorbidities, and patient preferences.

Sex Eligibility

Screening mammography under Section 1861(jj) is specifically defined as a service for women. Medicare also covers mammography for male beneficiaries when medically necessary as diagnostic mammography (HCPCS 77065 or 77066) but not as routine screening mammography under Section 1861(jj). Male breast cancer is rare (less than 1 percent of breast cancers), and routine screening mammography is not USPSTF-recommended for men.

Annual Frequency Reset Calculation

The annual frequency reset for screening mammography is calculated as follows:

• If the beneficiary's most recent screening mammography was on date X, the next screening mammography is covered on or after the first day of the month following the 12-month anniversary of date X.
• For example: Most recent screening mammography on June 15, 2026. Next screening mammography covered on or after July 1, 2027.

Some beneficiaries and providers misunderstand this calculation as requiring exactly 365 days between procedures. The correct rule is the first day of the month following the 12-month anniversary, which can be slightly more than 12 months after the prior procedure.

Part 3: Covered Technologies

Standard Digital Mammography (2D Mammography)

Standard digital mammography is the longstanding screening mammography modality. The procedure involves two-view imaging (craniocaudal and mediolateral oblique) of each breast for a total of four images per examination. Medicare covers standard digital mammography as the baseline screening mammography service under HCPCS 77067 (screening mammography bilateral two-view).

Standard digital mammography largely replaced film-based mammography in the early 2000s. Film mammography is no longer commonly used and is rarely covered.

Digital Breast Tomosynthesis (DBT, 3D Mammography)

Digital breast tomosynthesis (DBT, also known as 3D mammography) is an advanced mammography technology that acquires multiple low-dose images of the breast at different angles and uses computer reconstruction to produce thin-slice images allowing layered review of breast tissue. DBT improves detection of small cancers and reduces false-positive callbacks particularly in women with dense breast tissue.

Medicare covers DBT as an add-on to standard screening mammography through HCPCS 77063 (screening DBT add-on, listed in addition to the primary procedure 77067). Coverage applies when DBT imaging is performed in addition to standard 2D imaging.

Comparison of Standard Digital Mammography Versus DBT

Computer-Aided Detection (CAD)

Computer-aided detection (CAD) software historically allowed automated marking of suspicious findings on digital mammography for radiologist review. Medicare has variable CAD payment policies; CAD is typically bundled into the screening mammography payment rather than separately billed.

Diagnostic Mammography

Diagnostic mammography is performed when screening mammography identifies abnormal findings requiring additional imaging, when a woman has symptoms (palpable mass, breast pain, nipple discharge), or for follow-up after breast cancer treatment. Diagnostic mammography is billed under different HCPCS codes:

• HCPCS 77066: Diagnostic mammography bilateral with computer-aided detection when performed.
• HCPCS 77065: Diagnostic mammography unilateral with computer-aided detection when performed.

Diagnostic mammography is NOT covered under the ACA Section 4104 cost-sharing waiver because it is not screening. Diagnostic mammography is subject to standard Part B deductible plus 20 percent coinsurance.

This screening-to-diagnostic distinction can create unexpected cost-sharing similar to the screening-to-diagnostic colonoscopy issue. A woman who receives a callback for additional imaging after an abnormal screening mammography enters the diagnostic billing pathway with full Part B cost-sharing applying.

Part 4: Cost-Sharing Structure

ACA Section 4104 Cost-Sharing Waiver

Section 4104 of the Affordable Care Act (Public Law 111-148) eliminated Part B deductible and coinsurance for USPSTF Grade A or B aligned preventive services effective January 1, 2011. The USPSTF has graded screening mammography Grade B for women age 40 to 74 (per the 2024 USPSTF recommendation update, replacing the prior 2016 recommendation that had assigned Grade B for age 50 to 74 and Grade C for age 40 to 49).

The 2024 USPSTF update is particularly important because it aligned the recommendation with the longstanding Medicare coverage starting age (40) and removed the prior ambiguity at age 40 to 49.

Therefore, for screening mammography under HCPCS 77067 and the DBT add-on under HCPCS 77063, Medicare beneficiaries pay $0 when the procedure is performed by a Medicare-accepting provider at an MQSA-certified facility.

Cost-Sharing for Diagnostic Mammography

Diagnostic mammography under HCPCS 77065 (unilateral) or 77066 (bilateral) is NOT subject to the ACA Section 4104 cost-sharing waiver. Diagnostic mammography is subject to standard Part B cost-sharing:

• Part B deductible ($240 in 2024, adjusted annually).
• 20 percent coinsurance after deductible.

Supplemental Imaging Cost-Sharing

Supplemental imaging modalities — breast ultrasound, breast MRI — are not screening mammography under Section 1861(jj) and are not subject to the ACA Section 4104 waiver. Coverage and cost-sharing for supplemental imaging depend on medical necessity documentation:

• Breast ultrasound: Covered when medically necessary (for example, evaluation of palpable mass, supplemental screening in dense breast tissue with appropriate documentation, evaluation of abnormal mammography findings). Subject to standard Part B cost-sharing.
• Breast MRI: Covered when medically necessary for specific clinical indications (high-risk screening for women with BRCA mutations or strong family history, evaluation of newly diagnosed breast cancer, follow-up surveillance). Subject to standard Part B cost-sharing.

Cost-Sharing Summary Table

Part 5: Coordination With Other Medicare Preventive Services

Coordination With the Annual Wellness Visit

The Annual Wellness Visit (AWV), authorized by Section 1861(hhh) of the Social Security Act, includes a personalized prevention plan that documents preventive services status and recommendations. Mammography screening is a routine AWV component for women beneficiaries:

• Documentation of most recent mammography date and type.
• Risk assessment for breast cancer family history and other factors.
• Discussion of screening preferences.
• Referral for screening when due.
• Discussion of dense breast tissue notification (Georgia notification law) and supplemental imaging options if applicable.

Coordination With the Initial Preventive Physical Examination

The Initial Preventive Physical Examination (IPPE, the Welcome to Medicare visit) authorized by Section 1861(ww) is the one-time preventive visit available within the first 12 months of Part B enrollment. The IPPE includes assessment of preventive services needs and orders for appropriate screening including mammography.

Coordination With Diagnostic Mammography

When a screening mammography identifies abnormal findings (BI-RADS 0 incomplete, requiring additional imaging), the beneficiary returns for diagnostic mammography. The diagnostic mammography is billed under different HCPCS codes (77065 unilateral or 77066 bilateral) and is subject to standard Part B cost-sharing. This is an important counseling point pre-screening because some beneficiaries are surprised by the cost when called back for additional imaging.

Coordination With Supplemental Imaging

Beneficiaries with dense breast tissue (BI-RADS density category C or D) may benefit from supplemental imaging beyond standard mammography. Georgia requires dense breast tissue notification to women receiving mammography, and many women with dense breast tissue receive recommendations for supplemental breast ultrasound. High-risk women (BRCA mutations, strong family history, prior chest radiation for Hodgkin lymphoma) may receive recommendations for annual breast MRI in addition to annual mammography.

Part 6: Provider Requirements

Interpreting Physician Requirements (MQSA)

Under MQSA, interpreting physicians for screening mammography must meet specific qualifications:

• Be licensed to practice medicine in the state where the facility is located.
• Either have completed a residency or fellowship including mammography training, OR have completed at least 3 months of mammography training, OR have interpreted a minimum number of mammography examinations.
• Maintain continuing medical education in mammography (at least 15 hours every 36 months).
• Interpret a minimum of 960 mammograms over 24 months for continued qualification.

Radiologic Technologist Requirements (MQSA)

Under MQSA, radiologic technologists performing mammography must meet specific qualifications:

• Be certified by an appropriate body (American Registry of Radiologic Technologists, state licensure).
• Complete at least 40 hours of specific mammography training.
• Maintain continuing education in mammography (at least 15 hours every 36 months).
• Perform a minimum of 200 mammograms over 24 months for continued qualification.

Medical Physicist Requirements (MQSA)

Under MQSA, medical physicists conducting facility surveys must meet specific qualifications including state licensure where required, specific training and certification, and continuing education in mammography physics.

Georgia Provider Licensure

In Georgia, interpreting physicians (radiologists) are licensed by the Georgia Composite Medical Board. Radiologic technologists are licensed by the Georgia Composite Medical Board's Department of Radiologic Technology. All mammography facilities serving Medicare beneficiaries must be MQSA-certified by the FDA.

Part 7: The Major Georgia Breast Imaging Landscape

Atlanta Metropolitan Area

The Atlanta metropolitan area has extensive breast imaging capacity:

• Emory Breast Imaging Center — Academic comprehensive breast imaging at Emory University. Offers screening, diagnostic, ultrasound, MRI, and image-guided biopsy. 404-778-2020.
• Wellstar Breast Care — Network-wide breast imaging across the north and west Atlanta metropolitan area and surrounding regions.
• Piedmont Breast Health — Piedmont Healthcare breast imaging with multiple locations across the Atlanta metropolitan area and beyond.
• Northside Comprehensive Breast Care — Strong breast imaging program particularly noted for high mammography volume in the north Atlanta area.
• Grady Health System Breast Health Program — Safety-net hospital breast imaging serving central Atlanta.

Augusta and East Georgia

Augusta University Breast Health Center serves east Georgia with comprehensive breast imaging including screening, diagnostic, supplemental imaging, and image-guided biopsy. The CSRA (Central Savannah River Area) is also served by University Hospital and Doctors Hospital breast imaging programs.

Macon and Central Georgia

Atrium Health Navicent (Macon) and Coliseum Medical Centers provide breast imaging services for central Georgia. Houston Healthcare in Warner Robins serves Houston County.

Savannah and Coastal Georgia

Memorial Health (Savannah) and St. Joseph's Candler Telfair Pavilion provide breast imaging for coastal Georgia with comprehensive screening and diagnostic capabilities.

Albany and Southwest Georgia

Phoebe Putney Memorial Hospital (Albany) is the primary breast imaging resource for southwest Georgia, serving a large rural catchment.

Athens and Northeast Georgia

Piedmont Athens Regional and St. Mary's Health Care System provide breast imaging services for the Athens area and northeast Georgia.

Mobile Mammography Services

Mobile mammography services play a critical role in rural Georgia access. Several Georgia health systems operate mobile mammography units that travel to underserved counties:

• Grady Mobile Mammography.
• Northside Mobile Mammography.
• Augusta University Mobile Mammography.
• Phoebe Putney Mobile Mammography.

Mobile mammography units offer screening mammography services in community settings (churches, community centers, employer health fairs, FQHC partnerships) and bring MQSA-certified imaging to communities that otherwise lack convenient access.

Part 8: Breast Cancer Disease Burden in Georgia

Incidence and Mortality

Breast cancer is the most common cancer in women in Georgia and the second leading cause of cancer death (after lung cancer). The Georgia Comprehensive Cancer Registry consistently documents elevated breast cancer mortality particularly in African American women and in rural counties of south and southwest Georgia.

African American Mortality Disparities

African American women in Georgia experience breast cancer mortality at rates approximately 40 percent higher than non-Hispanic white women despite similar incidence rates. This disparity reflects multiple factors:

• Late-stage diagnosis at presentation, partly reflecting lower screening uptake.
• Higher rates of aggressive breast cancer subtypes (triple-negative breast cancer is more common in African American women).
• Treatment access disparities including delayed initiation of treatment after diagnosis.
• Persistent socioeconomic health disparities affecting insurance coverage and care access.

Rural Georgia Access

Rural Georgia counties face mammography access challenges including geographic distance to MQSA-certified facilities, limited transportation, and lower rates of preventive service utilization generally. Mobile mammography services partially address these gaps. Stool-based cancer screening modalities exist for colorectal cancer but no comparable home-based modality is available for breast cancer screening — mammography requires in-person imaging.

Dense Breast Tissue Notification

Georgia law requires that women receiving mammography be notified if their breast tissue is dense (BI-RADS category C or D). Dense breast tissue reduces the sensitivity of mammography for cancer detection and is itself an independent risk factor for breast cancer. The notification informs women about the option to discuss supplemental imaging with their providers.

Part 9: Worked Examples

Worked Example 1: Atlanta Age 67 Annual Screening Mammography

Beneficiary: 67-year-old woman in DeKalb County, no personal or family history of breast cancer, prior screening 12 months ago.

She receives her AWV at Emory primary care. Her primary care physician documents her last screening mammography (June 2025) and orders her current screening mammography. She schedules at Emory Breast Imaging Center.

Procedure: Standard digital mammography with DBT add-on (77067 + 77063). Imaging completed in approximately 20 minutes. Results read same-day by Emory radiologist: BI-RADS 1 (negative). Letter mailed to beneficiary and report sent to primary care physician.

Billing: 77067 and 77063 both subject to ACA Section 4104 cost-sharing waiver. Beneficiary pays $0. She is scheduled for her next annual screening on or after July 1, 2027.

Worked Example 2: Rural Southwest Georgia Mobile Mammography Access

Beneficiary: 70-year-old woman in Calhoun County (rural southwest Georgia, population approximately 5,000), no breast imaging facility in county.

Phoebe Putney Mobile Mammography schedules a community screening event at the Calhoun County Senior Center quarterly. The beneficiary receives notice through her FQHC primary care physician and schedules her annual mammography at the mobile event.

Procedure: Standard digital mammography (77067) on the mobile unit. Images transmitted electronically to Phoebe Putney for interpretation. Results: BI-RADS 2 (benign finding — stable calcifications). Letter mailed and primary care notified.

Billing: 77067 subject to ACA Section 4104 cost-sharing waiver. Beneficiary pays $0. She is scheduled for next annual mammography at the next Calhoun County mobile event in 12 months.

Worked Example 3: Dense Breast Tissue Supplemental Ultrasound

Beneficiary: 64-year-old woman in Cobb County, BI-RADS density category D (extremely dense), no family history of breast cancer.

Her annual screening mammography at Wellstar Breast Care shows extremely dense breast tissue limiting mammographic sensitivity. The radiologist documents dense breast tissue per Georgia notification law and recommends discussion of supplemental imaging.

The beneficiary discusses with her primary care physician who refers her for supplemental whole-breast ultrasound at Wellstar.

Procedure: Supplemental whole-breast ultrasound (CPT 76641 bilateral). Result: BI-RADS 2 (benign finding — small simple cyst). Combined screening exam is essentially negative.

Billing: Screening mammography (77067) subject to ACA Section 4104 waiver ($0 to beneficiary). Supplemental breast ultrasound (76641) is NOT subject to ACA Section 4104 waiver; it is subject to standard Part B deductible plus 20% coinsurance. Beneficiary pays applicable cost-sharing.

Worked Example 4: Abnormal Screening Referral to Diagnostic Mammography

Beneficiary: 69-year-old woman in Fulton County, annual screening mammography at Grady Health System.

Screening mammography (77067) shows an abnormality requiring additional imaging (BI-RADS 0 incomplete). The beneficiary receives a callback letter and schedules diagnostic mammography.

Procedure: Diagnostic mammography bilateral (77066) with additional spot compression views. Result: BI-RADS 3 (probably benign — short-interval follow-up recommended).

Billing: Original screening mammography (77067) was $0 to beneficiary. Diagnostic mammography (77066) is NOT subject to ACA Section 4104 waiver; standard Part B deductible plus 20% coinsurance applies. The beneficiary is informed of the cost-sharing distinction and the rationale.

She returns at 6 months for short-interval diagnostic follow-up (77066), again with standard Part B cost-sharing applying.

Worked Example 5: High-Risk Family History With Breast MRI

Beneficiary: 67-year-old woman in Athens-Clarke County, mother and sister both diagnosed with breast cancer before age 50, prior negative BRCA1/BRCA2 testing.

Strong family history qualifies her as high-risk despite negative BRCA testing. American Cancer Society and NCCN guidelines support annual screening with both mammography and breast MRI for women with elevated lifetime risk (typically greater than 20 percent by Tyrer-Cuzick or similar risk model).

Procedure: Annual screening mammography (77067 + 77063 DBT) at Piedmont Athens Regional. Six months later, annual screening breast MRI (CPT 77049 with and without contrast).

Billing: Mammography subject to ACA Section 4104 waiver ($0). Breast MRI is NOT subject to ACA Section 4104 waiver; standard Part B cost-sharing applies for the medically necessary high-risk surveillance MRI. The beneficiary is informed of the cost-sharing structure.

Worked Example 6: Baseline Screening for Woman Age 38 (Medicare Disability Eligibility)

Beneficiary: 38-year-old woman in Bibb County, enrolled in Medicare through Social Security Disability Insurance (SSDI) at age 36, no prior screening mammography.

She is eligible for the one-time baseline screening mammography under Section 1861(jj). Her primary care physician at Atrium Health Navicent discusses and orders the baseline screening.

Procedure: Screening mammography bilateral two-view (77067) at Atrium Health Navicent Breast Imaging. Result: BI-RADS 1 (negative).

Billing: 77067 subject to ACA Section 4104 waiver. Beneficiary pays $0.

She is now eligible for annual screening mammography starting at age 40 (in approximately 2 years).

Part 10: Best Practices

Best Practice 1: Verify MQSA Certification Before Scheduling

All mammography facilities serving Medicare beneficiaries must be MQSA-certified. Beneficiaries and providers can verify certification through the FDA's online MQSA-certified facility database.

Best Practice 2: Document Most Recent Mammography Date

The annual frequency reset depends on the date of the most recent screening mammography. Carefully documenting the date in the medical record supports correct scheduling and billing.

Best Practice 3: Discuss Dense Breast Tissue Counseling

Georgia law requires dense breast tissue notification, but the notification letter alone does not constitute clinical counseling. Discussing the implications of dense breast tissue and supplemental imaging options at the AWV provides appropriate context.

Best Practice 4: Pre-Counsel on Screening-to-Diagnostic Cost-Sharing

The screening-to-diagnostic distinction is a common source of beneficiary surprise. Pre-counseling at the AWV or before screening reduces confusion when callback bills arrive.

Best Practice 5: Coordinate Annual Mammography With AWV

Aligning annual mammography with the AWV creates an annual touchpoint that supports continuity, documentation, and care coordination. Many primary care practices schedule the AWV and order the annual mammography during the same visit.

Best Practice 6: Assess Family History Carefully

Strong family history may qualify the beneficiary for supplemental MRI screening. Carefully documenting first-degree and second-degree relative breast cancer history, age at diagnosis, and any ovarian cancer history supports appropriate risk assessment.

Best Practice 7: Discuss Continuation of Screening in Older Beneficiaries

Medicare has no upper age limit for screening mammography, but the clinical balance shifts at advanced age. Shared decision-making considering life expectancy, comorbidities, and patient preferences supports appropriate individualization.

Best Practice 8: Address Mobile Mammography Access for Rural Beneficiaries

Rural beneficiaries without local mammography facilities benefit from mobile mammography service coordination. Primary care practices in rural counties should partner with regional mobile mammography programs.

Best Practice 9: Coordinate Supplemental Imaging for Dense Breasts

Beneficiaries with extremely dense breast tissue (BI-RADS D) typically benefit from discussion of supplemental imaging. Coordinating this decision and follow-up at the AWV supports informed shared decision-making.

Best Practice 10: Document BRCA and Hereditary Risk Indications

Beneficiaries with strong family histories suggestive of BRCA1/BRCA2 or other hereditary breast cancer syndromes may benefit from genetic counseling and germline testing. Documenting indications and pursuing referrals when appropriate supports comprehensive care.

Best Practice 11: Confirm DBT Availability

Digital breast tomosynthesis (DBT) is widely available at major Georgia breast imaging centers but may not be available at all mobile mammography units or smaller facilities. Discussing DBT preference and confirming availability supports informed choice.

Best Practice 12: Coordinate Patient Communication of Results

MQSA requires patient communication of mammography results within 30 days of the examination. EHR-based patient portal results delivery has improved timeliness and reliability.

Best Practice 13: Refer Promptly After Abnormal Findings

BI-RADS 4 (suspicious) and BI-RADS 5 (highly suggestive of malignancy) findings require prompt biopsy. Streamlined referral pathways from screening through diagnostic imaging to biopsy support timely diagnosis and treatment.

Best Practice 14: Engage With Breast Cancer Survivorship Surveillance

After breast cancer treatment, beneficiaries transition from screening mammography to surveillance mammography. Coordinating surveillance with oncology specialists ensures appropriate follow-up.

Part 11: Common Issues

Common Issue 1: Confusion About Diagnostic Mammography Cost-Sharing

The most common cost-sharing surprise is the screening-to-diagnostic conversion. Beneficiaries who receive a callback for additional imaging are sometimes shocked by the cost of the diagnostic mammography compared to the $0 screening cost. Pre-counseling addresses this.

Common Issue 2: Frequency Reset Calculation Errors

The annual frequency reset is calculated from the first day of the month following the 12-month anniversary of the most recent screening mammography. Some beneficiaries and providers miscalculate this as exactly 365 days, producing scheduling errors.

Common Issue 3: Mobile Mammography MQSA Confusion

Some beneficiaries question whether mobile mammography units meet MQSA standards. All mobile mammography units serving Medicare beneficiaries are MQSA-certified. The FDA inspects mobile units under the same standards as fixed facilities.

Common Issue 4: DBT Availability Variability

DBT is widely available but not universal. Beneficiaries who specifically prefer DBT should confirm availability with the imaging facility before scheduling.

Common Issue 5: Supplemental Imaging Cost-Sharing Surprise

Beneficiaries with dense breast tissue who receive supplemental ultrasound or MRI sometimes do not realize that supplemental imaging is NOT subject to the ACA Section 4104 waiver. Pre-counseling addresses this.

Common Issue 6: Out-of-Network Imaging in Medicare Advantage

Medicare Advantage plans may have provider network constraints affecting where beneficiaries can receive screening mammography. Out-of-network use can produce higher cost-sharing even for ACA-aligned screening.

Common Issue 7: Breast Cancer Survivorship Surveillance Confusion

After breast cancer treatment, beneficiaries enter surveillance pathways rather than screening pathways. Surveillance mammography is sometimes billed as screening when it should be billed as diagnostic surveillance, producing incorrect cost-sharing.

Common Issue 8: Male Beneficiary Screening Coverage Confusion

Some male beneficiaries with breast symptoms believe screening mammography is covered. Screening mammography under Section 1861(jj) is specifically for women. Male beneficiaries may receive diagnostic mammography when medically necessary but not routine screening.

Common Issue 9: Documentation Gaps After Outside Imaging

When beneficiaries receive mammography at outside facilities, the procedure and findings may not be communicated back to the primary care record. This produces frequency interval gaps and potential billing complications.

Common Issue 10: Bilateral Versus Unilateral Confusion

Screening mammography is always bilateral (both breasts). Diagnostic mammography may be bilateral (77066) or unilateral (77065) depending on indication. Incorrect coding produces billing errors.

Common Issue 11: Symptomatic Patients Routed to Screening

Women with breast symptoms (palpable mass, pain, nipple discharge) should not undergo screening mammography under Section 1861(jj); they require diagnostic mammography. Routing symptomatic patients to screening produces incorrect billing and may miss timely diagnosis.

Common Issue 12: Failure to Address Implant Imaging

Beneficiaries with breast implants require specific mammography techniques (implant displacement views) and possibly supplemental imaging. Standard screening mammography in patients with implants may be inadequate without these techniques.

Common Issue 13: Genetic Risk Underrecognition

Beneficiaries with family histories suggestive of BRCA1/BRCA2 or other hereditary breast cancer syndromes are sometimes managed with standard screening rather than appropriate genetic counseling and high-risk surveillance protocols.

Common Issue 14: Patient Result Delivery Delays

MQSA requires patient communication within 30 days, but real-world delivery sometimes lags. EHR portal delivery and proactive results follow-up improve timeliness.

Frequently Asked Questions

1. What law established Medicare coverage for mammography screening?

Section 4163 of the Omnibus Budget Reconciliation Act of 1990 (Public Law 101-508), signed November 5, 1990, established the mammography screening benefit codified at Section 1861(jj) of the Social Security Act with coverage effective January 1, 1991.

2. When did annual mammography frequency begin?

Section 4101 of the Balanced Budget Act of 1997 (Public Law 105-33) established annual screening mammography frequency for women age 40 and older effective January 1, 1998.

3. What is the implementing regulation?

42 CFR 410.34 specifies the regulatory framework including covered services, frequency limits, facility requirements, and provider requirements.

4. At what age can I begin annual screening mammography?

Annual screening mammography is covered for women age 40 and older. There is also a one-time baseline screening mammography for women age 35 to 39.

5. Is there an upper age limit for screening mammography?

No. Medicare has no upper age limit for screening mammography. Annual coverage continues regardless of age, though clinical decisions about continuing screening typically involve shared decision-making at advanced age.

6. What is digital breast tomosynthesis (DBT)?

Digital breast tomosynthesis (DBT), also known as 3D mammography, is an advanced mammography technology that produces thin-slice reconstructed images. DBT improves cancer detection particularly in women with dense breast tissue.

7. Is DBT covered by Medicare?

Yes. DBT is covered as an add-on to standard screening mammography under HCPCS 77063 in addition to the primary screening code HCPCS 77067. The DBT add-on is subject to the ACA Section 4104 cost-sharing waiver and beneficiaries pay $0.

8. What is the HCPCS code for screening mammography?

HCPCS 77067 for screening mammography bilateral two-view. The DBT add-on is HCPCS 77063.

9. What is the HCPCS code for diagnostic mammography?

HCPCS 77066 for bilateral diagnostic mammography or HCPCS 77065 for unilateral diagnostic mammography.

10. Does Medicare cover the cost of screening mammography?

Yes. ACA Section 4104 waives Part B deductible and coinsurance for screening mammography. Beneficiaries pay $0.

11. What if I am called back for additional imaging?

The callback for additional imaging is diagnostic mammography (HCPCS 77065 or 77066) and is NOT subject to the ACA Section 4104 waiver. Standard Part B cost-sharing applies (deductible plus 20% coinsurance).

12. What is the Mammography Quality Standards Act?

The Mammography Quality Standards Act (MQSA, Public Law 102-539), signed October 27, 1992, establishes quality standards for all mammography facilities in the United States. The FDA administers MQSA through facility accreditation, annual inspections, personnel qualifications, equipment standards, quality assurance, and patient communication requirements.

13. Are mobile mammography units MQSA-certified?

Yes. All mobile mammography units serving Medicare beneficiaries are MQSA-certified by the FDA under the same standards as fixed facilities.

14. What is dense breast tissue?

Dense breast tissue refers to breasts with high fibroglandular content (BI-RADS density categories C heterogeneously dense or D extremely dense). Dense breast tissue reduces mammography sensitivity and is itself an independent breast cancer risk factor.

15. Does Georgia require dense breast tissue notification?

Yes. Georgia law requires that women receiving mammography be notified if their breast tissue is dense (BI-RADS category C or D).

16. Is breast ultrasound covered by Medicare?

Breast ultrasound is covered when medically necessary (palpable mass evaluation, abnormal mammography evaluation, supplemental imaging for dense breast tissue with appropriate documentation). It is NOT subject to the ACA Section 4104 waiver and standard Part B cost-sharing applies.

17. Is breast MRI covered by Medicare?

Breast MRI is covered for specific clinical indications (high-risk screening with BRCA mutations or strong family history, breast cancer diagnostic and surveillance, evaluation of certain abnormal findings). It is NOT subject to the ACA Section 4104 waiver and standard Part B cost-sharing applies.

18. What about screening mammography for men?

Screening mammography under Section 1861(jj) is specifically for women. Male beneficiaries may receive diagnostic mammography (HCPCS 77065 or 77066) when medically necessary but not routine screening.

19. What is the AWV?

The Annual Wellness Visit (Section 1861(hhh)) is a yearly Medicare-covered preventive visit that includes a personalized prevention plan documenting your mammography screening status and recommendations.

20. Can I have my mammography at any facility?

You can have your screening mammography at any MQSA-certified facility that accepts Medicare assignment under Original Medicare. Under Medicare Advantage, network constraints may apply.

21. How often is the FDA inspection of mammography facilities?

Annually. All MQSA-certified facilities are inspected annually by FDA-trained inspectors.

22. Does Medicare Advantage cover screening mammography?

Yes. Medicare Advantage plans must cover at least the same benefits as Original Medicare, including annual screening mammography at MQSA-certified facilities. Some plans offer enhanced benefits, but network constraints may apply.

23. How do I find an MQSA-certified facility in Georgia?

You can search the FDA's MQSA-certified facility database online, contact your primary care physician for a referral, or contact major Georgia breast imaging programs directly: Emory Breast Imaging Center (404-778-2020), Wellstar Breast Care, Piedmont Breast Health, Northside Comprehensive Breast Care, and Augusta University Breast Health.

24. What if I am newly diagnosed with breast cancer?

After breast cancer diagnosis, you transition from screening to active treatment and surveillance. Treatment costs are covered under standard Medicare benefits. After treatment, you enter surveillance mammography protocols which are billed differently than screening.

25. Does Medicare cover BRCA1/BRCA2 genetic testing?

Medicare covers BRCA1/BRCA2 germline testing in specific clinical contexts when medical necessity is documented. Coverage is determined by Local Coverage Determinations through the Medicare Administrative Contractor (Palmetto GBA for Georgia) and case-specific medical necessity review.

26. Where can I get help understanding my mammography screening coverage in Georgia?

Contact GeorgiaCares SHIP (1-866-552-4464) for free, unbiased Medicare counseling. You can also contact Medicare directly at 1-800-MEDICARE, the Medicare Rights Center at 1-800-333-4114, the American Cancer Society at 1-800-227-2345, or Susan G. Komen at 1-877-465-6636.

Contacts and Resources

1. Medicare — 1-800-MEDICARE (1-800-633-4227) for general Medicare questions and coverage.
2. Palmetto GBA Medicare Administrative Contractor — 1-866-238-9650 for Medicare claims and coverage in Georgia.
3. Georgia Department of Community Health Member Services — 1-866-211-0950 for Georgia Medicaid coordination.
4. GeorgiaCares SHIP — 1-866-552-4464 for free Medicare counseling.
5. Medicare Rights Center — 1-800-333-4114 for Medicare advocacy and assistance.
6. Atlanta Legal Aid — 404-377-0701 for legal assistance with Medicare issues.
7. Georgia Legal Services Program — 1-800-498-9469 for legal assistance outside metropolitan Atlanta.
8. 211 Georgia — Dial 211 for community resource referrals.
9. Eldercare Locator — 1-800-677-1116 for connection to local aging services.
10. Georgia Department of Public Health — 404-657-2700 for state public health resources.
11. American Cancer Society — 1-800-227-2345 for cancer information, support, and resources.
12. Susan G. Komen — 1-877-465-6636 for breast cancer information and patient support.
13. National Breast Cancer Foundation — 1-800-465-2624 for additional breast cancer information.
14. American College of Radiology — 1-800-227-5463 for ACR-accredited facility information.
15. Emory Breast Imaging Center — 404-778-2020 for academic breast imaging in Atlanta.
16. Wellstar Breast Care — Network-wide breast imaging in north and west Georgia.
17. Piedmont Breast Health — Piedmont Healthcare breast imaging across Georgia.
18. Acentra Health QIO — 1-844-455-8708 for Medicare quality of care concerns.